Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annuska Glas

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Surgical Oncology|November 3, 2009
Gene expression profiling: decoding breast cancerFemke de Snoo, Richard Bender, Annuska Glas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2006
Gene expression profiles of primary breast carcinomas from patients at high risk for local recurrence after breast-conserving therapyBas Kreike, Hans Halfwerk, Petra Kristel, et al.
Breast Cancer Research and Treatment|March 23, 2016
Equivalence of MammaPrint array types in clinical trials and diagnosticsInès Beumer, Anke Witteveen, Leonie Delahaye, et al.
Communications Biology|July 29, 2020
Controlling technical variation amongst 6693 patient microarrays of the randomized MINDACT trialLaurent Jacob, Anke Witteveen, Inès Beumer, et al.
NPJ Breast Cancer|September 27, 2017
DNA repair deficiency biomarkers and the 70-gene ultra-high risk signature as predictors of veliparib/carboplatin response in the I-SPY 2 breast cancer trialDenise M Wolf, Christina Yau, Ashish Sanil, et al.
The New England Journal of Medicine|December 20, 2002
A gene-expression signature as a predictor of survival in breast cancerMarc J van de Vijver, Yudong D He, Laura J van't Veer, et al.
JCO Precision Oncology|June 17, 2025
Immune Subtyping Identifies Patients With Hormone Receptor-Positive Early-Stage Breast Cancer Who Respond to Neoadjuvant Immunotherapy (IO): Results From Five IO Arms of the I-SPY2 TrialDenise M Wolf, Christina Yau, Michael Campbell, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Surgical Oncology|November 3, 2009
Gene expression profiling: decoding breast cancerFemke de Snoo, Richard Bender, Annuska Glas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2006
Gene expression profiles of primary breast carcinomas from patients at high risk for local recurrence after breast-conserving therapyBas Kreike, Hans Halfwerk, Petra Kristel, et al.
Breast Cancer Research and Treatment|March 23, 2016
Equivalence of MammaPrint array types in clinical trials and diagnosticsInès Beumer, Anke Witteveen, Leonie Delahaye, et al.
Communications Biology|July 29, 2020
Controlling technical variation amongst 6693 patient microarrays of the randomized MINDACT trialLaurent Jacob, Anke Witteveen, Inès Beumer, et al.
NPJ Breast Cancer|September 27, 2017
DNA repair deficiency biomarkers and the 70-gene ultra-high risk signature as predictors of veliparib/carboplatin response in the I-SPY 2 breast cancer trialDenise M Wolf, Christina Yau, Ashish Sanil, et al.
The New England Journal of Medicine|December 20, 2002
A gene-expression signature as a predictor of survival in breast cancerMarc J van de Vijver, Yudong D He, Laura J van't Veer, et al.
JCO Precision Oncology|June 17, 2025
Immune Subtyping Identifies Patients With Hormone Receptor-Positive Early-Stage Breast Cancer Who Respond to Neoadjuvant Immunotherapy (IO): Results From Five IO Arms of the I-SPY2 TrialDenise M Wolf, Christina Yau, Michael Campbell, et al.
Pageof 1